Cosmeceuticals and peptides

Clinics in Dermatology

Volumn 27, Issue 5, 2009, Pages 485-494

  Zhang, Lijuan ^a   Falla, Timothy J ^a  

^a Helix Biomedix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL HEXAPEPTIDE 3; ACETYL OCTAPEPTIDE 1; ACETYL TETRAPEPTIDE 2; ACETYL TETRAPEPTIDE 5; ACETYLPEPTIDE 1; ALPHA INTERMEDIN; ARGIRELINE; BOTULINUM TOXIN A; CALCIPOTRIOL; COSMETIC; DIPEPTIDE; DIPEPTIDE 2; DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE; HEXAPEPTIDE 10; KOJIC ACID; MATRIXYL; NONAPEPTIDE 1; OLIGOPEPTIDE 10; OLIGOPEPTIDE 20; PALMITOYL HEXAPEPTIDE 6; PALMITOYL OLIGOPEPTIDE; PALMITOYL PENTAPEPTIDE 3; PALMITOYL TETRAPEPTIDE 7; PALMITOYL TRIPEPTIDE 5; PENTAPEPTIDE 3; PEPTIDE; RIGIN; SYNTHETIC PEPTIDE; TRIPEPTIDE; TRIPEPTIDE 1; TRIPEPTIDE 10 CITRULLINE; TRIPEPTIDE 2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL REACTION; DERMATOLOGY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; SKIN CARE;

ADMINISTRATION, CUTANEOUS; CELL PROLIFERATION; COSMETICS; DERMATITIS; DRUG DESIGN; FEMALE; FORECASTING; HUMANS; IMMUNITY, INNATE; MALE; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PIGMENTATION DISORDERS; SKIN ABSORPTION; SKIN AGING; SKIN CARE; SKIN DISEASES;

EID: 68649106177     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.05.013     Document Type: Article

References (100)

1. Pierard G.E. EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. Part 1: relevance to the structures and ageing of the skin and subcutaneous tissues. Skin Pharmacol Appl Skin Physiol 12 (1999) 352-362
2. Woodley D.T., O'Keefe E.J., and Prunieras M. Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol 12 (1985) 420-433
3. Adams J.C., and Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 117 (1993) 1183-1198
4. Smith L.T., Holbrook K.A., and Madri J.A. Collagen types I, III, and V in human embryonic and fetal skin. Am J Anat 175 (1986) 507-521
5. Maquart F.X., Pasco S., Ramont L., Hornebeck W., and Monboisse J.C. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol 49 (2004) 199-202
6. Labat-Robert J. Cryptic sites and matrikines: cellular effects of fibronectin and laminin peptides. J Soc Biol 197 (2003) 45-51
7. Tran K.T., Lamb P., and Deng J.S. Matrikines and matricryptins: Implications for cutaneous cancers and skin repair. J Dermatol Sci 40 (2005) 11-20
8. Swindle C.S., Tran K.T., Johnson T.D., et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 154 (2001) 459-468
9. Pirila E., Sharabi A., Salo T., et al. Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 303 (2003) 1012-1017
10. Hornebeck W., and Maquart F.X. Role of matrikins in melanoma progression. Ann Pharm Fr 64 (2006) 83-86
11. Tran K.T., Griffith L., and Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 12 (2004) 262-268
12. Aycock R.S., Raghow R., Stricklin G.P., Seyer J.M., and Kang A.H. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem 261 (1986) 14355-14360
13. Katayama K., Seyer J.M., Raghow R., and Kang A.H. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 30 (1991) 7097-7104
14. Katayama K., Armendariz-Borunda J., Raghow R., Kang A.H., and Seyer J.M. Apentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 268 (1993) 9941-9944
15. Price L.S., Roos P.J., Shively V.P., and Sandberg L.B. Valyl-alanyl-prolyl-glycine (VAPG) serves as a quantitative marker for human elastins. Matrix 13 (1993) 307-311
16. Grosso L.E., and Scott M. PGAIPG, a repeated hexapeptide of bovine tropoelastin, is a ligand for the 67-kDa bovine elastin receptor. Matrix 13 (1993) 157-164
17. Sandberg L.B., Wolt T.B., and Leslie J.G. Quantitation of elastin through measurement of its pentapeptide content. Biochem Biophys Res Commun 136 (1986) 672-678
18. Duca L., Floquet N., Alix A.J., Haye B., and Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 49 (2004) 235-244
19. Kunitomo M., and Jay M. Elastin fragment-induced monocyte chemotaxis. The role of desmosines. Inflammation 9 (1985) 183-188
20. Fulop Jr. T., Jacob M.P., Varga Z., Foris G., Leovey A., and Robert L. Effect of elastin peptides on human monocytes: Ca2+ mobilization, stimulation of respiratory burst and enzyme secretion. Biochem Biophys Res Commun 141 (1986) 92-98
21. Senior R.M., Griffin G.L., Mecham R.P., Wrenn D.S., Prasad K.U., and Urry D.W. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 99 (1984) 870-874
22. Uemura Y., and Okamoto K. Elastin-derived peptide induces monocyte chemotaxis by increasing intracellular cyclic GMP level and activating cyclic GMP dependent protein kinase. Biochem Mol Biol Int 41 (1997) 57-64
23. Hornebeck W., Robinet A., Duca L., Antonicelli F., Wallach J., and Bellon G. The elastin connection and melanoma progression. Anticancer Res 25 (2005) 2617-2625
24. Long M.M., King V.J., Prasad K.U., Freeman B.A., and Urry D.W. Elastin repeat peptides as chemoattractants for bovine aortic endothelial cells. J Cell Physiol 140 (1989) 512-518
25. Blood C.H., Sasse J., Brodt P., and Zetter B.R. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 107 (1988) 1987-1993
26. Blood C.H., and Zetter B.R. Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. J Biol Chem 264 (1989) 10614-10620
27. Robinet A., Fahem A., Cauchard J.H., et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 118 (2005) 343-356
28. Kamoun A., Landeau J.M., Godeau G., et al. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhes Commun 3 (1995) 273-281
29. Pickart L., and Thaler M.M. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol 243 (1973) 85-87
30. Pickart L., Thayer L., and Thaler M.M. Asynthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells. Biochem Biophys Res Commun 54 (1973) 562-566
31. Maquart F.X., Pickart L., Laurent M., Gillery P., Monboisse J.C., and Borel J.P. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 238 (1988) 343-346
32. Arul V., Gopinath D., Gomathi K., and Jayakumar R. Biotinylated GHK peptide incorporated collagenous matrix: A novel biomaterial for dermal wound healing in rats. J Biomed Mater Res B Appl Biomater 73 (2005) 383-391
33. Arul V., Kartha R., and Jayakumar R. Atherapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sci 80 (2007) 275-284
34. Maquart F.X., Bellon G., Chaqour B., et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest 92 (1993) 2368-2376
35. Pickart L., and Thaler M.M. Growth-modulating human plasma tripeptide: relationship between molecular structure and DNA synthesis in hepatoma cells. FEBS Lett 104 (1979) 119-122
36. Pickart L., and Thaler M.M. Growth-modulating tripeptide (glycylhistidyllysine): association with copper and iron in plasma, and stimulation of adhesiveness and growth of hepatoma cells in culture by tripeptide-metal ion complexes. J Cell Physiol 102 (1980) 129-139
37. Poole T.J., and Zetter B.R. Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. Cancer Res 43 (1983) 5857-5861
38. Zetter B.R., Rasmussen N., and Brown L. An in vivo assay for chemoattractant activity. Lab Invest 53 (1985) 362-368
39. Grosse G., and Lindner G. Experimental influence of pharmacological agents on the regeneration of nervous tissue in vitro. Folia Morphol (Praha) 28 (1980) 345-347
40. Raju K.S., Alessandri G., Ziche M., and Gullino P.M. Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 69 (1982) 1183-1188
41. Lane T.F., Iruela-Arispe M.L., Johnson R.S., and Sage E.H. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 125 (1994) 929-943
42. Wegrowski Y., Maquart F.X., and Borel J.P. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci 51 (1992) 1049-1056
43. Pickart L., and Lovejoy S. Biological activity of human plasma copper-binding growth factor glycyl-L-histidyl-L-lysine. Methods Enzymol 147 (1987) 314-328
44. Mulder G.D., Patt L.M., Sanders L., et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen 2 (1994) 259-269
45. Simeon A., Emonard H., Hornebeck W., and Maquart F.X. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci 67 (2000) 2257-2265
46. Zhang L., and Falla T.J. Antimicrobial peptides: therapeutic potential. Expert Opin Pharmacother 7 (2006) 653-663
47. Braff M.H., and Gallo R.L. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr Top Microbiol Immunol 306 (2006) 91-110
48. Harder J., and Schroder J.M. Antimicrobial peptides in human skin. Chem Immunol Allergy 86 (2005) 22-41
49. Braff M.H., Hawkins M.A., Di Nardo A., et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174 (2005) 4271-4278
50. Kurosaka K., Chen Q., Yarovinsky F., Oppenheim J.J., and Yang D. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol 174 (2005) 6257-6265
51. Shaykhiev R., Beisswenger C., Kandler K., et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289 (2005) L842-L848
52. Tokumaru S., Sayama K., Shirakata Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175 (2005) 4662-4668
53. Lee P.H., Rudisill J.A., Lin K.H., et al. HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair Regen 12 (2004) 351-358
54. Flad T., Bogumil R., Tolson J., et al. Detection of dermcidin-derived peptides in sweat by ProteinChip technology. J Immunol Methods 270 (2002) 53-62
55. Bardan A., Nizet V., and Gallo R.L. Antimicrobial peptides and the skin. Expert Opin Biol Ther 4 (2004) 543-549
56. Sorensen O.E., Thapa D.R., Rosenthal A., Liu L., Roberts A.A., and Ganz T. Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 174 (2005) 4870-4879
57. Chen X., Niyonsaba F., Ushio H., et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 40 (2005) 123-132
58. Lopez-Garcia B., Lee P.H., Yamasaki K., and Gallo R.L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125 (2005) 108-115
59. Nizet V., Ohtake T., Lauth X., et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (2001) 454-457
60. Lee P.H., Ohtake T., Zaiou M., et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci U S A 102 (2005) 3750-3755
61. Howell M.D., Wollenberg A., Gallo R.L., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 117 (2006) 836-841
62. Rieg S., Steffen H., Seeber S., et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174 (2005) 8003-8010
63. Mookherjee N., Brown K.L., Bowdish D.M., et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176 (2006) 2455-2464
64. McInturff J.E., Wang S.J., Machleidt T., et al. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol 125 (2005) 256-263
65. Mallbris L., Edstrom D.W., Sundblad L., Granath F., and Stahle M. UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol 125 (2005) 1072-1074
66. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 571 (2005) 107-120
67. Carsberg C.J., Warenius H.M., and Friedmann P.S. Ultraviolet radiation-induced melanogenesis in human melanocytes. Effects of modulating protein kinase C. J Cell Sci 107 (1994) 2591-2597
68. Burchill S.A., Virden R., and Thody A.J. Regulation of tyrosinase synthesis and its processing in the hair follicular melanocytes of the mouse during eumelanogenesis and phaeomelanogenesis. J Invest Dermatol 93 (1989) 236-240
69. Suzuki I., Cone R.D., Im S., Nordlund J., and Abdel-Malek Z.A. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137 (1996) 1627-1633
70. Abdel-Malek Z.A., Kadekaro A.L., Kavanagh R.J., et al. Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. Faseb J 20 (2006) 1561-1563
71. Seiberg M., Paine C., Sharlow E., et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 115 (2000) 162-167
72. Suzuki I., Tada A., Ollmann M.M., et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 108 (1997) 838-842
73. Park H.Y., Russakovsky V., Ohno S., and Gilchrest B.A. The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 268 (1993) 11742-11749
74. Park H.Y., Russakovsky V., Ao Y., Fernandez E., and Gilchrest B.A. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp Cell Res 227 (1996) 70-79
75. Kwon B.S., Haq A.K., Pomerantz S.H., and Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci U S A 84 (1987) 7473-7477
76. Park H.Y., Lee J., Gonzalez S., et al. Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol 122 (2004) 159-166
77. Scott C.P., Abel-Santos E., Wall M., Wahnon D.C., and Benkovic S.J. Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci U S A 96 (1999) 13638-13643
78. Kim H., Choi J., Cho J.K., Kim S.Y., and Lee Y.S. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity. Bioorg Med Chem Lett 14 (2004) 2843-2846
79. Noh J.M., Kwak S.Y., Kim D.H., and Lee Y.S. Kojic acid-tripeptide amide as a new tyrosinase inhibitor. Biopolymers 88 (2007) 300-307
80. Rao S., Lang C., Levitan E.S., and Deitcher D.L. Visualization of neuropeptide expression, transport, and exocytosis in Drosophila melanogaster. J Neurobiol 49 (2001) 159-172
81. Bonifacino J.S., and Glick B.S. The mechanisms of vesicle budding and fusion. Cell 116 (2004) 153-166
82. Luger T.A. Neuromediators-a crucial component of the skin immune system. J Dermatol Sci 30 (2002) 87-93
83. Fu F.N., Lomneth R.B., Cai S., and Singh B.R. Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry 37 (1998) 5267-5278
84. Blanes-Mira C., Clemente J., Jodas G., et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci 24 (2002) 303
85. Molles B.E., Tsigelny I., Nguyen P.D., Gao S.X., Sine S.M., and Taylor P. Residues in the epsilon subunit of the nicotinic acetylcholine receptor interact to confer selectivity of waglerin-1 for the alpha-epsilon subunit interface site. Biochemistry 41 (2002) 7895-7906
86. Allolio B., and Arlt W. DHEA treatment: myth or reality?. Trends Endocrinol Metab 13 (2002) 288-294
87. Kim S.K., Shin M.S., Jung B.K., et al. Effect of dehydroepiandrosterone on lipopolysaccharide-induced interleukin-6 production in DH82 cultured canine macrophage cells. J Reprod Immunol 70 (2006) 71-81
88. Mills S.J., Ashworth J.J., Gilliver S.C., Hardman M.J., and Ashcroft G.S. The sex steroid precursor DHEA accelerates cutaneous wound healing via the estrogen receptors. J Invest Dermatol 125 (2005) 1053-1062
89. Navolotskaya E.V., Zargarova T.A., Lepikhova T.N., et al. Study of immunosuppressive activity of a synthetic decapeptide corresponding to an ACTH-like sequence of human immunoglobulin G1. Biochemistry (Mosc) 64 (1999) 758-764
90. Rocchi R., Biondi L., Cavaggion F., et al. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives. Int J Pept Protein Res 29 (1987) 262-275
91. Yang Y., Marczak E.D., Yokoo M., Usui H., and Yoshikawa M. Isolation and antihypertensive effect of angiotensin I-converting enzyme (ACE) inhibitory peptides from spinach Rubisco. J Agric Food Chem 51 (2003) 4897-4902
92. Schwab A., Macerata R., Rogers W., Barton J., Skiles J., and Khandwala A. Inhibition of angiotensin-converting enzyme by dipeptide analogs. Res Commun Chem Pathol Pharmacol 45 (1984) 339-345
93. Marczak E.D., Usui H., Fujita H., et al. New antihypertensive peptides isolated from rapeseed. Peptides 24 (2003) 791-798
94. Ohtsuki K., Abe A., Mitsuzumi H., et al. Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature. J Nutr Sci Vitaminol (Tokyo) 49 (2003) 447-450
95. Hirata A., Murakami Y., Shoji M., Kadoma Y., and Fujisawa S. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Res 25 (2005) 3367-3374
96. Bos J.D., and Meinardi M.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9 (2000) 165-169
97. Partidos C.D., Beignon A.S., Brown F., Kramer E., Briand J.P., and Muller S. Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination. J Control Release 85 (2002) 27-34
98. Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Control Release 86 (2003) 69-92
99. Lopes L.B., Brophy C.M., Furnish E., et al. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Pharm Res 22 (2005) 750-757
100. Lopes L.B., Collett J.H., and Bentley M.V. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm 60 (2005) 25-30